{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "360", "lead_paragraph": "Horizon Pharma is a recent entrant on the merger scene, so its low debt load and small size mean it can easily expand. Look for more deals to come.", "pub_date": "2015-07-08T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Horizon Pharma\u2019s Bid for Depomed Leaves Room to Grow  ", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "Horizon Pharma is a recent entrant on the merger scene, so its low debt load and small size mean it can easily expand. Look for more deals to come.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/07/08/business/dealbook/horizon-pharmas-bid-for-depomed-leaves-room-to-grow.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Horizon Pharma Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Depomed Inc", "name": "organizations"}], "blog": [], "_id": "559c266d38f0d81b1af2d3ed", "source": "The New York Times"}